Professor Roy Fleischmann from the University of Texas Southwestern Medical Center, Dallas.
Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Roy Fleischmann discusses the safety and efficacy of long-term baricitinib monotherapy in RA.
